Status:
COMPLETED
MRE as a Screening Tool for axSpA in IBD
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Axial Spondyloarthritis
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess the effectiveness (specificity and sensitivity) of using magnetic resonance enterography (MRE) as a screening tool for axial spondyloarthritis (axSpA) in patients with Crohns...
Detailed Description
Spondyloarthritis (SpA) is a term that encompasses psoriatic arthritis with axial disease, ankylosing spondylitis and non-radiological axial spondyloarthritis. The prevalence of SpA in the general pop...
Eligibility Criteria
Inclusion
- Subjects who are willing and able to give informed consent for participation in the study.
- Male and female subjects aged 18 years or above.
- Diagnosed by the gastroenterology team with Crohn's disease.
- MRE imaging since 2015 for their Crohn's disease.
Exclusion
- 1\. Subjects unwilling or unable to give informed consent.
Key Trial Info
Start Date :
March 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2020
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT03817983
Start Date
March 4 2019
End Date
August 8 2020
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology Research Unit
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ